Construction of a ferroptosis scoring system and identification of LINC01572 as a novel ferroptosis suppressor in lung adenocarcinoma.

导出 LinkOut

翻译打印收藏纠错

作者： Lingling,Hong ^[1] ; Xuehai,Wang ^[2] ; Weiming,Cui ^[3] ; Fengxu,Wang ^[2] ; Weiwei,Shi ^[1] ; Shali,Yu ^[2] ; Yonghua,Luo ^[4] ; Lixin,Zhong ^[5] ; Xinyuan,Zhao ^[2]

作者单位： Nantong Hospital of Traditional Chinese Medicine, Affiliated Traditional Chinese Medicine Hospital of Nantong University, Nantong, China. ^[1] Department of Occupational Medicine and Environmental Toxicology, Nantong Key Laboratory of Environmental Toxicology, School of Public Health, Nantong University, Nantong, China. ^[2] Department of Thoracic and Cardiac Surgery, Nanjing Brain Hospital, Nanjing, China. ^[3] Nantong Fourth People's Hospital, Nantong, China. ^[4] Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China. ^[5]

关键词 LINC01572 N6-methyladenosine (m6A) methylation ferroptosis long non-coding RNA lung adenocarcinoma signature

DOI 10.3389/fphar.2022.1098136

PMID 36686701

发布时间 2023-02-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2022年13卷

1098136页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Construction of a ferroptosis scoring system and identification of LINC01572 as a novel ferroptosis suppressor in lung adenocarcinoma.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Construction of a ferroptosis scoring system and identification of LINC01572 as a novel ferroptosis suppressor in lung adenocarcinoma.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除